SANGAMO THERAPEUTICS Genome/Gene Editing Technology Reviews

Are you from this Company?
SANGAMO THERAPEUTICS
California, USA
1995
$51MN to $100MN
Enterprise
60 Likes
71 Buyers Negotiating

Summary

Sangamo offers products majorly in the ZFN Transcription Factors category. Their services include ZFP Transcription Factors (ZFP TFs) and ZFP Nucleases (ZFN).

Discussions

Strengths
  • +14
    CRISPR
  • +14
    How long products are offered in the market
  • +8
    Technical Customer Support
  • +9
    Animal GE
  • +8
    Cell Line Engineering
  • +10
    Plant GE
  • +5
    TELEN
  • +11
    Breadth and Depth of Product Offerings
  • +5
    Product Differentiation and Impact on Customer Value
  • +12
    Product Features and Functionality
  • +14
    Product Quality and Reliability
  • +13
    Focus on Product Innovation
  • +13
    New Products Launched by company in the last 3 years
  • +6
    ZFN
  • +11
    Other Applications
  • +7
    Antisense
  • +8
    PiggyBac, Flp-In, and Jump-In
nostrength
No Cautions to show
I agree to 360Quadrants Terms of use and privacy policy
Success
info
Error
Company Size :
  Enterprise
  SME
  Startup